8-Chloroadenosine
- Generic Name
- 8-Chloroadenosine
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C10H12ClN5O4
- CAS Number
- 34408-14-5
- Unique Ingredient Identifier
- PA05MFH3I7
- Background
8-Chloroadenosine is under investigation in clinical trial NCT02509546 (8-chloroadenosine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia).
- Associated Conditions
- -
- Associated Therapies
- -
8-Chloroadenosine in Combination With Venetoclax for the Treatment of Patients With Relapsed/Refractory Acute Myeloid Leukemia
Phase 1
Suspended
- Conditions
- Interventions
- First Posted Date
- 2022-03-02
- Last Posted Date
- 2024-11-07
- Lead Sponsor
- City of Hope Medical Center
- Target Recruit Count
- 30
- Registration Number
- NCT05263284
- Locations
- 🇺🇸
City of Hope Medical Center, Duarte, California, United States
8-Chloroadenosine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- First Posted Date
- 2015-07-28
- Last Posted Date
- 2023-12-05
- Lead Sponsor
- City of Hope Medical Center
- Target Recruit Count
- 20
- Registration Number
- NCT02509546
- Locations
- 🇺🇸
City of Hope Medical Center, Duarte, California, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath